Martin MacKay

Martin MacKay

Founder at RALLYBIO CORPORATION

Net worth: 4 M $ as of 2024-03-30

68 year
Health Technology
Commercial Services
Technology Services

Profile

Martin W.
MacKay
is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-20 11,600 ( 0.02% ) 3 M $ 2024-03-30
2024-02-14 719,126 ( 1.90% ) 1 M $ 2024-03-30

Martin MacKay active positions

CompaniesPositionStart
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director/Board Member 2017-07-04
NOVO NORDISK A/S Director/Board Member 2018-02-28
RALLYBIO CORPORATION Founder 2017-12-31
Director/Board Member -
Chief Executive Officer -
Chief Executive Officer 2017-12-31
Chief Executive Officer 2010-12-21
All active positions of Martin MacKay

Former positions of Martin MacKay

CompaniesPositionEnd
501 ACQU Director/Board Member 2022-04-21
ALEXION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2017-05-31
░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Martin MacKay's experience

Training of Martin MacKay

The University of Edinburgh Doctorate Degree
Heriot-Watt University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin MacKay's experience

Connections

100 +

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

VERISIGN. INC.

Technology Services

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Commercial Services

NOVO NORDISK A/S

Health Technology

RALLYBIO CORPORATION

Health Technology

Private companies20

Health Technology

Health Technology

Technology Services

Commercial Services

Communications

Process Industries

Technology Services

Finance

Health Technology

Commercial Services

Commercial Services

Technology Services

Commercial Services

Technology Services

Commercial Services

Ciba-Geigy Pharmaceuticals

Beecham Pharmaceuticals (UK)

Commercial Services

Health Services

Finance

See company connections